SLS Stock-Based Compensation
Sellas Life Sciences Group Inc · Stock-Based Compensation
SLS Stock-Based Compensation
Latest reported$2.76Mperiod ending
SLS TTM Stock-Based Comp ($1.78M → $2.76M)
TTM stock-based compensation
High-resolution chart · PNG
SLS stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 2,763,000 | |
| 2,249,000 | |
| 1,956,000 | |
| 1,882,000 | |
| 1,760,000 | |
| 1,593,000 | |
| 1,564,000 | |
| 1,688,000 | |
| 1,850,000 | |
| 2,030,000 | |
| 2,094,000 | |
| 2,043,000 | |
| 1,955,000 | |
| 1,891,000 | |
| 1,726,000 | |
| 1,568,000 | |
| 1,388,000 | |
| 1,202,000 | |
| 1,011,000 | |
| 864,000 | |
| 735,000 | |
| 617,000 | |
| 578,000 | |
| 584,000 | |
| 553,000 | |
| 533,000 | |
| 573,000 | |
| 537,000 | |
| 559,000 | |
| 558,000 | |
| 395,000 | |
| 2,877,000 | |
| 2,891,000 | |
| 2,963,000 | |
| 3,169,000 | |
| 1,010,000 | |
| 1,411,000 | |
| 1,836,000 | |
| 2,264,000 | |
| 2,427,000 | |
| 1,937,000 | |
| 1,960,000 | |
| 1,931,000 | |
| 2,286,000 | |
| 3,523,000 | |
| 4,391,000 | |
| 5,387,000 | |
| 5,621,000 | |
| 5,051,000 | |
| 3,905,000 | |
| 2,530,000 | |
| 1,937,000 | |
| 1,388,000 | |
| 1,215,000 | |
| 1,394,000 | |
| 1,001,000 | |
| 1,812,000 | |
| 2,114,000 | |
| 3,001,000 | |
| 3,711,000 | |
| 3,553,000 | |
| 4,483,000 | |
| 4,368,000 | |
| 4,608,000 | |
| 4,427,000 | |
| 4,742,000 | |
| 4,202,000 | |
| 3,052,000 | |
| 2,400,000 | |
| 2,544,000 | |
| 2,514,000 | |
| 2,514,000 | |
| 2,950,000 | |
| 2,406,000 | |
| 1,777,000 | |
| 1,777,000 |